The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth (Q40542555)
Jump to navigation
Jump to search
scientific article published on July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth |
scientific article published on July 2004 |
Statements
1 reference
The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth (English)
1 reference
Fumiaki Nozawa
1 reference
Atsushi Itami
1 reference
Murat Saruc
1 reference
Min Kim
1 reference
Jens Standop
1 reference
Kathleen S Picha
1 reference
Kenneth H Cowan
1 reference
Parviz M Pour
1 reference
1 July 2004
1 reference
1 reference
29
1 reference
1
1 reference
45-52
1 reference
Identifiers
1 reference
1 reference